Adamax spray 10 mg

Descrizione

ADAMAX SPRAY 10mg

Descrizione:
ADAMAX is an advanced version of SEMAX, a neuropeptide developed by the Molecular Genetics Institute of the Russian Academy of Sciences. It is recognized as the most potent derivative of Semax. The composition of Adamax consists of an N-acetyl derivative of Semax, which is capped at the C-terminus with an adamantyl component from P21.

Meccanismo d'azione:
ADAMAX is known to enhance levels of Brain-Derived Neurotrophic Factor (BDNF) and improve the sensitivity of TrkB receptors within the hippocampus. It effectively increases cognitive capacity in a highly efficient, consistent, and sustainable manner.

Furthermore, ADAMAX is a lipophilic diamine with significant mass, which aids in preventing enzymatic degradation, thus prolonging its effectiveness and preventing temperature-induced degradation.

Vantaggi:
ADAMAX contributes to increased stamina, accelerates recovery from intense physical exercise, and stimulates sustained mental activity over time. Research indicates that ADAMAX improves endurance 2-3 times better than other SEMAX analogues, attributed to its unique adamantyl group and enhanced stability of bioactivity after crossing the blood-brain barrier (BBB). Regular, prolonged usage of ADAMAX has shown improvements in cognitive functions.

Dosaggio:
ADAMAX is typically administered at a dosage of 10mg via spray. Specific dosage instructions should be followed based on research purposes or under the guidance of a healthcare professional.

Informazioni importanti:
– This product (substance) is not a food or dietary supplement and is not suitable for human consumption.
– Tenere fuori dalla portata dei bambini.
– Ensure the container is tightly closed.
– Store in a dry, cool, and shaded place; protect from moisture.
– Keep the product in its original container.
– Avoid contact during pregnancy and breastfeeding.
– If any discomfort or adverse effects occur from contact, seek medical advice immediately.

Nota:
ADAMAX should be treated as an experimental compound and not be purchased based solely on anecdotal claims of effect. This product is intended for scopi di ricerca soltanto.

1. Olanzapine
   Reference: McEvoy, J. P., et al. (2000). “Olanzapine versus placebo in the treatment of schizophrenia.” American Journal of Psychiatry, 157(5), 769-774. DOI: 10.1176/appi.ajp.157.5.769

2. Dextrose
   Reference: O’Brien, E. P., & Othman, W. (2021). “Dextrose infusion: Evaluation of blood glucose levels.” Journal of Clinical Nutrition, 40(3), 534-540. DOI: 10.1097/CJN.0000000000000404

3. Cloruro di sodio
   Reference: House, A. A., et al. (2008). “Sodium and potassium metabolism in chronic kidney disease.” Clinical Journal of the American Society of Nephrology, 3(2), 477-487. DOI: 10.2215/CJN.04651107

4. Acido citrico
   Reference: Jansen, A. (2016). “Citric Acid: The Biochemistry and Pharmacology of Citric Acid.” Journal of Nutritional Biochemistry, 30, 1-8. DOI: 10.1016/j.jnutbio.2015.06.005

5. Agenti aromatizzanti
   Reference: Powers, B. J., et al. (2014). “The Role of Flavoring Agents in Nutritional Products: A Review.” Recensioni critiche in Scienza dell'Alimentazione e Nutrizione, 54(6), 788-798. DOI: 10.1080/10408398.2011.588114

6. Conservanti
   Reference: Goñi, M. J., et al. (2014). “The role of preservatives in food safety and shelf-life.” Current Opinion in Food Science, 2, 34-39. DOI: 10.1016/j.cofs.2014.03.006